153 related articles for article (PubMed ID: 16041241)
21. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells.
Ohmori S; Nakasa H; Asanome K; Kurose Y; Ishii I; Hosokawa M; Kitada M
Biochim Biophys Acta; 1998 May; 1380(3):297-304. PubMed ID: 9555064
[TBL] [Abstract][Full Text] [Related]
22. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
23. Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene.
Hara H; Yasunami Y; Adachi T
Biochem Biophys Res Commun; 2004 Sep; 321(4):909-15. PubMed ID: 15358113
[TBL] [Abstract][Full Text] [Related]
24. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture.
Greuet J; Pichard L; Bonfils C; Domergue J; Maurel P
Biochem Biophys Res Commun; 1996 Aug; 225(2):689-94. PubMed ID: 8753820
[TBL] [Abstract][Full Text] [Related]
25. Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.
Williams JA; Ring BJ; Cantrell VE; Jones DR; Eckstein J; Ruterbories K; Hamman MA; Hall SD; Wrighton SA
Drug Metab Dispos; 2002 Aug; 30(8):883-91. PubMed ID: 12124305
[TBL] [Abstract][Full Text] [Related]
26. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples.
Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegård J; Jeppsson B; Edwards RJ; Boobis AR; Rane A
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):240-8. PubMed ID: 17371528
[TBL] [Abstract][Full Text] [Related]
27. Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers.
Vyhlidal CA; Bi C; Ye SQ; Leeder JS
Drug Metab Dispos; 2016 Jul; 44(7):1020-6. PubMed ID: 26772622
[TBL] [Abstract][Full Text] [Related]
28. Helices F-G are important for the substrate specificities of CYP3A7.
Torimoto N; Ishii I; Toyama K; Hata M; Tanaka K; Shimomura H; Nakamura H; Ariyoshi N; Ohmori S; Kitada M
Drug Metab Dispos; 2007 Mar; 35(3):484-92. PubMed ID: 17178770
[TBL] [Abstract][Full Text] [Related]
29. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.
Schuetz JD; Beach DL; Guzelian PS
Pharmacogenetics; 1994 Feb; 4(1):11-20. PubMed ID: 8004129
[TBL] [Abstract][Full Text] [Related]
30. Expression and induction of CYP3As in human fetal hepatocytes.
Matsunaga T; Maruyama M; Harada E; Katsuyama Y; Sugihara N; Ise H; Negishi N; Ikeda U; Ohmori S
Biochem Biophys Res Commun; 2004 May; 318(2):428-34. PubMed ID: 15120618
[TBL] [Abstract][Full Text] [Related]
31. Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.
Koch I; Weil R; Wolbold R; Brockmöller J; Hustert E; Burk O; Nuessler A; Neuhaus P; Eichelbaum M; Zanger U; Wojnowski L
Drug Metab Dispos; 2002 Oct; 30(10):1108-14. PubMed ID: 12228187
[TBL] [Abstract][Full Text] [Related]
32. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
Crettol S; Venetz JP; Fontana M; Aubert JD; Pascual M; Eap CB
Ther Drug Monit; 2008 Dec; 30(6):689-99. PubMed ID: 18978522
[TBL] [Abstract][Full Text] [Related]
33. Effects of cytochrome b(5) on drug oxidation activities of human cytochrome P450 (CYP) 3As: similarity of CYP3A5 with CYP3A4 but not CYP3A7.
Yamaori S; Yamazaki H; Suzuki A; Yamada A; Tani H; Kamidate T; Fujita Ki; Kamataki T
Biochem Pharmacol; 2003 Dec; 66(12):2333-40. PubMed ID: 14637191
[TBL] [Abstract][Full Text] [Related]
34. Catalysis of the 4-hydroxylation of retinoic acids by cyp3a7 in human fetal hepatic tissues.
Chen H; Fantel AG; Juchau MR
Drug Metab Dispos; 2000 Sep; 28(9):1051-7. PubMed ID: 10950848
[TBL] [Abstract][Full Text] [Related]
35. Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7.
Neunzig I; Drăgan CA; Widjaja M; Schwaninger AE; Peters FT; Maurer HH; Bureik M
Biochim Biophys Acta; 2011 Jan; 1814(1):161-7. PubMed ID: 20637317
[TBL] [Abstract][Full Text] [Related]
36. Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450.
Inoue E; Takahashi Y; Imai Y; Kamataki T
Biochem Biophys Res Commun; 2000 Mar; 269(2):623-7. PubMed ID: 10708604
[TBL] [Abstract][Full Text] [Related]
37. [Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].
Bácsi K; Kósa J; Lazáry A; Balla B; Horváth H; Takács I; Nagy Z; Speer G; Lakatos P
Orv Hetil; 2007 Jul; 148(27):1273-80. PubMed ID: 17604264
[TBL] [Abstract][Full Text] [Related]
38. Variability in Expression of CYP3A5 in Human Fetal Liver.
Vyhlidal CA; Pearce RE; Gaedigk R; Calamia JC; Shuster DL; Thummel KE; Leeder JS
Drug Metab Dispos; 2015 Aug; 43(8):1286-93. PubMed ID: 25979262
[TBL] [Abstract][Full Text] [Related]
39. Efficient complementary DNA directed expression of human fetal liver cytochrome P450 (CYP3A7) in insect cells using baculovirus.
Sakuma T; Kitamura R; Yokoi T; Kamataki T
Biochem Mol Biol Int; 1995 Feb; 35(2):447-55. PubMed ID: 7663401
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice.
Cheung C; Yu AM; Chen CS; Krausz KW; Byrd LG; Feigenbaum L; Edwards RJ; Waxman DJ; Gonzalez FJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1328-34. PubMed ID: 16291874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
